Shots:

• Xinhua Healthcare to get exclusive license rights to commercialize ArcDia’s mariPOC platform in China. ArcDia to supply biochemical assay components and R&D services to Xinhua
• The focus of the collaboration is to expand Xinhua’s IVD business in point-of-care testing (POCT) and localize ArcDia’s mariPOC technology in addition to building up of a production capacity for decentralized infection diagnostic services in China
• ArcDia’s mariPOC IVD platform is an automated POC test system designed for the rapid multianalyte identification and detection of pathogens & inflammation markers focusses on respiratory tract infections- tonsillitis and gastroenteritis 

Ref: ArcDia | Image: Twitter